Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?
about
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer.Targeting thyroid cancer microenvironment: basic research and clinical applications.Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.
P2860
Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical outcome, role of BRAF ...... e of papillary thyroid cancer?
@en
Clinical outcome, role of BRAF ...... e of papillary thyroid cancer?
@nl
type
label
Clinical outcome, role of BRAF ...... e of papillary thyroid cancer?
@en
Clinical outcome, role of BRAF ...... e of papillary thyroid cancer?
@nl
prefLabel
Clinical outcome, role of BRAF ...... e of papillary thyroid cancer?
@en
Clinical outcome, role of BRAF ...... e of papillary thyroid cancer?
@nl
P2860
P356
P1476
Clinical outcome, role of BRAF ...... e of papillary thyroid cancer?
@en
P2093
Alfredo Pontecorvi
Carmelo Nucera
P2860
P356
10.3389/FENDO.2012.00033
P577
2012-02-27T00:00:00Z